1 / 10

East Coast Investment Overview: MAA, NE, NYMA, SE

East Coast Investment Overview: MAA, NE, NYMA, SE. January 17, 2003. Our Outlook from Last Year – What We Said. Larger funds, big deals Increased valuation pressures – down rounds No near-term IPO liquidity Big ideas, serial entrepreneurs raise big bucks

smichael
Télécharger la présentation

East Coast Investment Overview: MAA, NE, NYMA, SE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Venture Capital Advisory Group East Coast Investment Overview:MAA, NE, NYMA, SE January 17, 2003

  2. Our Outlook from Last Year – What We Said • Larger funds, big deals • Increased valuation pressures – down rounds • No near-term IPO liquidity • Big ideas, serial entrepreneurs raise big bucks • Increased global competition for key deals • Seed funding “gap” for modest deals • “Healthcare only” funds increase • Cash conservation for later rounds

  3. East Coast Life Science VC Investment:MAA, MNYA, NE, SE *Includes preliminary figures for 4Q 2002

  4. East Coast LS Investment 2002 Deals & Dollars By Segment Deals Dollars Medical IS 12% $199 M Medical IS 23% 37 Deals Medical Devices 18% $292 M Biopharma Biopharma 52% 84 Deals 65% $1090 M Medical Devices 19% 31 Deals Healthcare Services 5% $78 M Healthcare Services 6% 10 Deals *Includes preliminary figures for 4Q 2002

  5. 2002 East Coast LS Deals By Round Class Deals Dollars: Corporate Corporate Other Other 2% $34 M 5% 8 Deals 9% 13 Deals 15% $236 M Seed/First 21% $335 M Later Seed/First 26% 39 Deals Later 32% 50 Deals 30% $483 M Second 32% $500 M Second 28% 42 Deals

  6. East Coast Areas Investment Breakout New York Metro Mid-Atlantic Southeast New England

  7. Most Active Investors With East Coast Site

  8. Most Active Investors: No East Coast Site

  9. MAA - Most Active Investors In 2002 • Ben Franklin Technology Partners • JPMorgan Partners • NEA • InterWest • Perseus-Soros BioPharmaceutical Fund • Prism

  10. Outlook for 2003 • FDA will lead the way • Activity is up already in 2003 • Aldulazyme, Fabrazyme, Aralast • Still too many companies in the industry • Contraction • Consolidation • Other 2002 outlooks are on track

More Related